Related references
Note: Only part of the references are listed.Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
Geraldine H. Petit et al.
PLOS ONE (2013)
Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity
Julie Chapuis et al.
NATURE NEUROSCIENCE (2012)
Olfactory Deficits and Cognitive Dysfunction in Parkinson's Disease
Teresa Parrao et al.
NEURODEGENERATIVE DISEASES (2012)
Hyposmia in Parkinson's disease
Maria Victoria Alvarez et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Functional Rehabilitation of Cadmium-Induced Neurotoxicity Despite Persistent Peripheral Pathophysiology in the Olfactory System
Lindsey A. Czarnecki et al.
TOXICOLOGICAL SCIENCES (2012)
Odor Identification Deficits Identify Parkinson's Disease Patients with Poor Cognitive Performance
Malene Flensborg Damholdt et al.
MOVEMENT DISORDERS (2011)
Parkinson's Disease Symptoms: The Patient's Perspective
Marios Politis et al.
MOVEMENT DISORDERS (2010)
Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevalence of smell loss in Parkinson's disease - A multicenter study
A. Haehner et al.
PARKINSONISM & RELATED DISORDERS (2009)
Lack of improvement in odor identification by levodopa in humans
Nina Roesser et al.
PHYSIOLOGY & BEHAVIOR (2008)
Olfactory loss may be a first sign of idiopathic Parkinson's disease
Antje Haehner et al.
MOVEMENT DISORDERS (2007)
Normative data for the Sniffin' Sticks including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects
T. Hummel et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2007)
Clinical significance of results from olfactory testing
Volker Gudziol et al.
LARYNGOSCOPE (2006)
Olfactory function in patients with idiopathic Parkinson's disease:: effects of deep brain stimulation in the subthalamic nucleus
T Hummel et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Olfactory disorders and their consequences for quality of life
T Hummel et al.
ACTA OTO-LARYNGOLOGICA (2005)
Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
MBH Youdim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
MM Ponsen et al.
ANNALS OF NEUROLOGY (2004)
Evidence for peripheral plasticity in human odour response
LW Wang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders
I Litvan et al.
MOVEMENT DISORDERS (2003)
Neuroprotection by propargylamines in Parkinson's disease - Suppression of apoptosis and induction of prosurvival genes
W Maruyama et al.
NEUROTOXICOLOGY AND TERATOLOGY (2002)
Clinical assessment of retronasal olfactory function
S Heilmann et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2002)
Share Paper
